Recruiting studies: Stage Iii Breast Cancer Ajcc V7

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT03941756 Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Phase 2 · 7 location(s) · Jonsson Comprehensive Cancer Center · NCT05595499 Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Can
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05417308 Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagn
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT02918474 A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07443943 Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Can
Phase 2 · 7 location(s) · City of Hope Medical Center · NCT06954831 An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast
Phase 1 · 1 location(s) · Mayo Clinic · NCT06999798 Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-S
NA · 4 location(s) · Emory University · NCT06534125 Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel i
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092373 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Phase 2 · 1 location(s) · Mayo Clinic · NCT07044310 Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advan
Phase 2 · 1 location(s) · Roswell Park Cancer Institute · NCT06434064 Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Phase 3 · 3 location(s) · City of Hope Medical Center · NCT06763328 Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06042569 [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer
Phase 2 · 1 location(s) · Asan Medical Center · NCT07314073 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · 544 location(s) · National Cancer Institute (NCI) · NCT06058377 Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07158021 TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NA · 4 location(s) · Dana-Farber Cancer Institute · NCT05535192 The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
Phase N/A · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07341503 A Study of Revaree Plus in People With Breast Cancer
Phase 4 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07042581 Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06401889 Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
Phase N/A · 3 location(s) · Gene Solutions · NCT06087120 Neoadjuvant Breast Cancer Time Restricted Eating
NA · 1 location(s) · Thomas Jefferson University · NCT05327608 Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally A
Phase 2 · 1 location(s) · Mayo Clinic · NCT07460752 Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast
Phase 2 · 2 location(s) · University of Washington · NCT06179303 Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast
EARLY_Phase 1 · 4 location(s) · Emory University · NCT05464810 Improving Exercise Capacity With a Tailored Physical Activity Intervention
NA · 2 location(s) · Wake Forest University Health Sciences · NCT05595577 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · 482 location(s) · National Cancer Institute (NCI) · NCT05564377 Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Phase 3 · 109 location(s) · European Organisation for Research and Treatment of Cancer - · NCT05512364 Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatm
Phase 2 · 1 location(s) · University of Washington · NCT04329065 A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NA · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT07095114

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →